All In Biotech

Drug Trial Radar · NCT06887972

A Single-Arm Study Evaluating the Effectiveness and Safety of Suzetrigine (SUZ) for Acute Pain After Aesthetic or Reconstructive Surgeries

A Phase 4, Open-label, Single-arm Study Evaluating the Effectiveness and Safety of Suzetrigine As Part of Multimodal Therapy for Acute Pain After Aesthetic or Reconstructive Surgeries

Last checked: Nov 20, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

100

Actual

Start

Mar 21, 2025

Primary completion

Oct 24, 2025

Study completion Nov 7, 2025

Sponsor

Lead sponsor
Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
Sponsor type
Industry
First posted
Mar 21, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study evaluates the effectiveness, safety, and tolerability of SUZ as part of multimodal therapy (MMT) in treating acute postoperative pain.

Conditions

  • Acute Pain

Interventions

  • SuzetrigineDrug

    Tablets for oral administration.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Reporting Good, Very Good, or Excellent on a Patient Global Assessment (PGA) for Pain Control at the End of TreatmentTime frame: Day 14 or at Pain Resolution, whichever occurs first

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Atlanta Center for Medical Research

    Atlanta, Georgia

  • Beth Israel Deaconess Medical Center - Surgery

    Boston, Massachusetts

  • HD Research LLC | First Surgical Hospital

    Bellaire, Texas

  • Memorial Hermann Village

    Houston, Texas

  • JBR Clinical Research

    Salt Lake City, Utah

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.